Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from…

By J. Byrd, K. Mrózek, R. Dodge, A. Carroll, C. Edwards, D. Arthur, M. Pettenati, S. Patil, K. Rao, M. Watson and 9 more. Blood, 2002

1,671 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/97d297906589b1716b0adb65b98e49192298bd9d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. H. Kantarjian

Citations in the corpus

• Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation (2007, result): “Intriguingly, results from two acute myeloid leukaemia (AML) studies support a role for reduced MAD1 function in cancer progression, as monosomy for the chromosome that contains MAD1 was correlated with a poor 5-year survival rat”
• Report of an international working group to standardize response criteria for myelodysplastic syndromes. (2000, background): “MDS will exclude cases of low-blast-count leukemias that show one of the following AML type cytogenetic abnormalities: t(8;21), inv(16), or t(15;17).”